3-Amino-4-bromopyridine

Catalog No.: 
ACKNXV759
CAS No.: 
239137-39-4
Molecular Formula: 
C5H5BrN2
Molecular Weight: 
173.01
3-Amino-4-bromopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$80.00In stockInquiry
100g97%$317.00In stockInquiry
500g97%$1265.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Amino-4-bromopyridine
IUPAC Name4-bromopyridin-3-amine
MDL No.MFCD04112575
Molecular FormulaC5H5BrN2
Molecular Weight173.01
SMILESNC1=C(C=CN=C1)Br
InChI KeyLKQGBXRGSPSTES-UHFFFAOYSA-N
Synonym3-Amino-4-bromopyridine | 239137-39-4 | 4-bromopyridin-3-amine | 4-BROMO-PYRIDIN-3-YLAMINE | 3-Pyridinamine, 4-bromo- | MFCD04112575 | 4-bromo-3-pyridylamine | SCHEMBL758890 | DTXSID20376592 | LKQGBXRGSPSTES-UHFFFAOYSA-N | BBL100699 | STL554493 | 3-Amino-4-bromopyridine, Aldrich
CAS No.239137-39-4
PubChem CID2762938

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKNXV759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYLDE903 route compound structure diagram
    ACYLDE90323056-44-2In Stock
  2. Then
  3. ACKNXV759 route product structure diagram
    ACKNXV759239137-39-4In Stock
Inquiry

2. ACKNXV759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMRLT471 route compound structure diagram
    ACMRLT47113534-90-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACKNXV759 route product structure diagram
    ACKNXV759239137-39-4In Stock
Inquiry

3. ACKNXV759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKNXV759 route product structure diagram
    ACKNXV759239137-39-4In Stock
Inquiry

Comments (0)